Group 1 - Hillenbrand, Inc. has completed the divestiture of its minority stake in TerraSource Holdings to Astec Industries for approximately $245 million [1] - Hillenbrand received about $115 million from the transaction, which will be used to pay down debt [1] Group 2 - Hillenbrand is a global industrial company providing highly-engineered processing equipment and solutions [2] - The company's portfolio includes leading industrial brands serving markets such as durable plastics, food, and recycling [2] - Hillenbrand is guided by its purpose to shape solutions that serve its people, customers, and communities [2]

Group 1 - Highland Copper Company has engaged Velocity Trade Capital Ltd. to provide market making services to improve liquidity and reduce trading volatility of its shares [1][2] - The monthly fee for these market liquidity services is set at $6,000, with a termination clause allowing either party to end the contract with 30 days' notice after 60 days [2] - Velocity Trade is a registered independent investment dealer in Canada and is regulated by multiple international authorities, ensuring compliance and credibility [3][4] Group 2 - Highland Copper Company focuses on exploring and developing copper projects in Michigan, owning the Copperwood deposit and a 34% stake in the White Pine North project [5] - The company has 736,363,619 common shares issued and outstanding, listed on the TSX Venture Exchange under the symbol "HI" and on the OTCQB under "HDRSF" [5]

Core Points - Hillenbrand, Inc. announced the departure of CFO Robert "Bob" VanHimbergen, effective June 27, 2025, to pursue another position outside the company [1][2] - Megan Walke, currently Vice President and Corporate Controller, will serve as Interim CFO following VanHimbergen's departure [2] - The company has engaged an executive search firm to find a permanent CFO [2] - CEO Kim Ryan acknowledged VanHimbergen's contributions in transforming Hillenbrand into a pure-play industrial company and emphasized the company's strong positioning for future strategies [3] Company Overview - Hillenbrand is a global industrial company that provides highly-engineered, mission-critical processing equipment and solutions [8] - The company's portfolio includes leading industrial brands serving large markets such as durable plastics, food, and recycling [8] - Hillenbrand is guided by its purpose to shape solutions that best serve its people, customers, and communities [8]

VANCOUVER, British Columbia, May 14, 2025 (GLOBE NEWSWIRE) -- Highland Copper Company Inc. (TSXV: HI; OTCQB: HDRSF) ("Highland" or the "Company") is pleased to provide an update on recent developments at its 100%-owned Copperwood Project ("Copperwood") and the White Pine North Project ("White Pine"), a joint venture with Kinterra Copper USA LLC ("Kinterra"). Highland continues to advance Copperwood toward a near-term construction decision through a phased approach to detailed engineering which is designed t ...

Group 1 - Hillenbrand, Inc. has declared a regular quarterly cash dividend of $0.225 per share on its common stock [1] - The dividend is scheduled to be payable on June 30, 2025, to shareholders of record as of June 16, 2025 [1] Group 2 - Hillenbrand is a global industrial company providing highly-engineered, mission-critical processing equipment and solutions [2] - The company serves customers in over 100 countries and has a portfolio of leading industrial brands [2] - Key end markets include durable plastics, food, and recycling [2] - The company's purpose is to shape solutions that best serve its associates, customers, communities, and stakeholders [2]

Financial Data and Key Metrics Changes - Revenue for the second quarter was $716 million, down 9% year-over-year primarily due to reduced volume from a lower starting backlog [18] - Adjusted EBITDA decreased 19% to $99 million, with a margin of 13.8%, down 180 basis points compared to the prior year [19] - GAAP net loss was $41 million, a decline from a profit of $6 million in the previous year, attributed to a non-cash loss on the majority sale of Milacron [19] - Adjusted earnings per share were $0.60, down 21% year-over-year but exceeded expectations due to favorable interest expenses [19] Business Line Data and Key Metrics Changes - Advanced Process Solutions (APS) segment saw year-over-year improvement in capital orders for Food, Health, and Nutrition (FHN) products, but larger investments were paused due to tariff uncertainties [11] - Molding Technology Solutions (MTS) revenue decreased 2% year-over-year to $222 million, primarily due to unfavorable foreign exchange [22] - Backlog for MTS was $55 million, excluding the Milacron business, with stable orders for hot runner and mold-based components [23] Market Data and Key Metrics Changes - The ongoing global macroeconomic uncertainty, driven by tariffs, has led to a decline in business and consumer confidence, resulting in delays in customer investment plans [10] - The company noted a strong project pipeline but faced slow conversion to orders due to macro-driven timing rather than a fundamental shift in market position [12] - Tariff impacts have caused multinational customers to pause orders, particularly in China, with a potential shift of orders to India [13] Company Strategy and Development Direction - The company is focusing on highly engineered, value-added processing technologies and systems, targeting less cyclical global end markets [7] - A strategic milestone was achieved with the completion of the Milacron transaction, allowing the company to concentrate on core strengths [6] - The company is implementing cost control initiatives and maintaining focus on growth opportunities in FHN and service offerings despite current challenges [12] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the project pipeline but acknowledged that macroeconomic uncertainties are expected to persist [10] - The updated outlook anticipates total revenue of approximately $2.56 billion to $2.62 billion, significantly down from previous guidance due to lower orders [25] - Management remains confident in the long-term demand drivers for their end markets despite current headwinds [28] Other Important Information - The company has included approximately $15 million in direct tariff costs in its updated outlook for the remainder of the year [16] - Net debt at the end of the second quarter was $1.46 billion, with a net debt to pro forma adjusted EBITDA ratio of 3.4 times [24] - The company is in the process of selling the TerraSource global business for $245 million, with expected net proceeds of approximately $100 million to be used for debt reduction [24] Q&A Session Summary Question: Can you describe the order cadence you saw in the business as the quarter unfolded? - Orders were stable through February but faced delays due to tariff considerations, particularly in Food, Health, and Nutrition [32][34] Question: Can you talk about synergies related to the FHN businesses? - The company is on track to achieve synergies ahead of schedule, with significant integration initiatives already completed [38][40] Question: Which lever to offset tariffs will have the most immediate impact? - Dual sourcing is expected to have the largest near-term impact, with targeted pricing adjustments also being implemented [45] Question: Can you walk us through the TerraSource divestiture? - The TerraSource divestiture is expected to close by the end of Q3 or early Q4, with proceeds primarily used to pay down debt [49][50] Question: What is the outlook for the macro environment? - The company is assuming a mild recession, with expectations for orders to decline from 2024 levels [78]

Financial Data and Key Metrics Changes - Revenue for the second quarter was $716 million, down 9% year-over-year primarily due to reduced volume from a lower starting backlog [19] - Adjusted EBITDA decreased 19% to $99 million, with a margin of 13.8%, down 180 basis points compared to the prior year [20] - GAAP net loss was $41 million, compared to income of $6 million in the prior year, largely due to a non-cash loss on the majority sale of Milacron [20] - Adjusted earnings per share were $0.60, a decrease of 21% year-over-year but exceeded expectations due to favorable interest expense [20] Business Line Data and Key Metrics Changes - Advanced Process Solutions (APS) segment saw year-over-year improvement in capital orders for Food, Health, and Nutrition (FHN) products, but larger investments were paused due to tariff uncertainties [12][19] - Molding Technology Solutions (MTS) revenue was $222 million, a decrease of 2% year-over-year, with stable orders for hot runner and mold-based components [23] - Backlog for MTS was $55 million, excluding the Milacron business, indicating a stable order environment despite macro challenges [24] Market Data and Key Metrics Changes - The ongoing global macroeconomic uncertainty, driven by tariffs, has led to a decline in business and consumer confidence, resulting in delays in customer investment plans [10] - The company noted a strong project pipeline but faced slow conversion to orders due to the unpredictable environment [9][10] - Tariffs have significantly impacted customer sentiment, particularly in China, leading to a pause in orders for the hot runner business [14] Company Strategy and Development Direction - The company is focusing on its core strengths in highly engineered, value-added processing technologies and systems, targeting less cyclical global end markets [6] - A strategic shift towards leveraging expertise in systems design and process technology is emphasized to drive long-term growth [7] - The company is actively managing its supply chain to mitigate tariff impacts, including dual sourcing and adjusting contract terms [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about the project pipeline but acknowledged that elevated uncertainty is expected to persist in the near term [10][18] - The updated outlook anticipates total revenue of approximately $2.56 billion to $2.62 billion, significantly down from previous guidance due to lower orders [27] - Management remains confident in the long-term demand drivers for their end markets despite current challenges [30] Other Important Information - The company has entered into a definitive agreement to sell the TerraSource global business for $245 million, with expected net proceeds of approximately $100 million to be used for debt reduction [26] - The company has included approximately $15 million in direct tariff costs in its updated outlook for the remainder of the year [17] Q&A Session Summary Question: Can you describe the order cadence you saw in the business as the quarter unfolded? - Orders were stable through February but faced delays due to tariff considerations, particularly in Food, Health, and Nutrition [34][35] Question: Can you talk about synergies related to the FHN businesses? - The company is on track to achieve synergies ahead of schedule, with significant integration initiatives already completed [40][41] Question: Which lever to offset tariffs is expected to have the most immediate impact? - Dual sourcing is expected to have the largest near-term impact, with targeted pricing actions also being implemented [47] Question: Can you provide an update on the TerraSource divestiture? - The TerraSource divestiture is expected to close by the end of Q3 or early Q4, with proceeds aimed at debt reduction [51][52] Question: What is the outlook for the macro environment? - The company anticipates a mild recession, with orders expected to decline from 2024 levels [78]

Second Quarter FY 2025 Earnings Call Presentation April 30, 2025 Disclosure Regarding Forward-Looking Statements Throughout this earnings presentation, we make a number of "forward-looking statements," including statements that are within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, and that are intended to be covered by the safe harbor provided under these secti ...

Company Performance - Hillenbrand reported quarterly earnings of $0.60 per share, exceeding the Zacks Consensus Estimate of $0.54 per share, but down from $0.76 per share a year ago [1] - The earnings surprise for the quarter was 11.11%, and the company has surpassed consensus EPS estimates in all four of the last quarters [2] - Revenues for the quarter were $715.9 million, which surpassed the Zacks Consensus Estimate by 3.60%, but decreased from $785.3 million year-over-year [3] Market Context - Hillenbrand shares have declined approximately 27% since the beginning of the year, compared to a 6% decline in the S&P 500 [4] - The current consensus EPS estimate for the upcoming quarter is $0.67 on revenues of $622 million, and for the current fiscal year, it is $2.57 on revenues of $2.68 billion [8] Industry Outlook - The Industrial Services industry, to which Hillenbrand belongs, is currently ranked in the bottom 43% of over 250 Zacks industries, indicating potential challenges ahead [9] - The performance of Hillenbrand's stock may be influenced by the overall outlook for the industry, as top-ranked industries tend to outperform the bottom-ranked ones significantly [9]

Divestiture and Financial Impact - Hillenbrand completed the divestiture of its majority interest in the Milacron injection molding and extrusion business for total consideration of $286.0 million, consisting of $98.0 million in cash and $188.0 million in debt assumed by Bain Capital[95]. - The company recorded a pre-tax loss of $54.6 million from the Milacron divestiture during the three and six months ended March 31, 2025[98]. - Hillenbrand incurred $4.1 million in transaction costs associated with the Milacron divestiture during the reporting period[98]. - Loss on divestiture amounted to $54.6 million due to the divestiture of Milacron[122]. - Order backlog decreased by $175.1 million (76%) from $229.8 million at March 31, 2024, to $54.7 million at March 31, 2025, mainly due to the Milacron divestiture[138]. - Consolidated net loss increased by $47.2 million (549%) for the three months ended March 31, 2025, primarily due to a loss on the divestiture of Milacron[157]. Financial Performance Metrics - The company utilizes adjusted EBITDA as a key non-GAAP financial measure to monitor business performance, which excludes certain expenses related to acquisitions and restructuring[103]. - Net revenue for the three months ended March 31, 2025, decreased by $69.4 million (9%) compared to the same period in 2024[110]. - Gross profit for the same period decreased by $14.3 million (6%), with a gross profit margin improvement of 110 basis points to 33.0%[111]. - Advanced Process Solutions net revenue decreased by $65.2 million (12%), primarily due to a decrease in volume[125]. - Adjusted EBITDA from continuing operations decreased by $23.8 million (19%) for the three months ended March 31, 2025, primarily driven by lower volume and cost inflation[158]. - Consolidated adjusted EBITDA from continuing operations decreased by $40.9 million (17%) for the six months ended March 31, 2025, compared to the same period in 2024, primarily due to lower volume and cost inflation[160]. Expenses and Cost Management - Selling, general and administrative expenses decreased by $1.6 million (1%), with these expenses as a percentage of net revenue increasing by 200 basis points to 25.1%[112]. - Selling, general and administrative expenses for the six months ended March 31, 2025, increased by $11.6 million (3%) compared to the same period in 2024[120]. - Selling, general and administrative expenses decreased by $10.9 million (20%) for the three months ended March 31, 2025, primarily due to a decrease in restructuring costs[140]. - Corporate expenses increased by $2.0 million (11%) for the three months ended March 31, 2025, primarily due to higher business acquisition costs[151]. - Amortization expense decreased by $1.5 million (17%) for the three months ended March 31, 2025, primarily due to the impact of the Milacron divestiture[142]. Revenue and Backlog - Backlog represents expected net revenue from awarded contracts, with fulfillment timelines ranging from days for aftermarket parts to 18-24 months for larger systems[104]. - The company expects future net revenue to be influenced by order backlog, although fluctuations may occur due to order timing and customer delivery dates[105]. - Order backlog decreased by $282.2 million (15%) from $1,877.1 million at March 31, 2024, to $1,594.9 million at March 31, 2025[126]. Tax and Interest - The effective tax rate was 12.9% in 2025 compared to 32.8% in 2024, primarily driven by a decrease in unrecognized tax benefits[115]. - Interest expense, net decreased by $7.6 million (25%) due to the impact of cross-currency swaps[114]. Cash Flow and Liquidity - Cash flows from operating activities from continuing operations used $10.0 million during the six months ended March 31, 2025, compared to $20.8 million used in the same period in 2024, reflecting a $10.8 million decrease[173]. - Net cash flows from investing activities increased by $118.7 million during the six months ended March 31, 2025, primarily due to proceeds from the divestiture of Milacron[175]. - Cash provided by financing activities from continuing operations increased by $142.2 million during the six months ended March 31, 2025, largely due to net borrowing activity[176]. - The company returned $31.7 million to shareholders in the form of quarterly dividends during the six months ended March 31, 2025, with an increase in the quarterly dividend to $0.2250 per common share from $0.2225 per common share in 2024[177]. - The company believes its current liquidity position is sufficient to meet all financial commitments in the current business environment[171]. Current Assets and Liabilities - Current assets as of March 31, 2025, totaled $881.9 million, while current liabilities were $1,275.2 million[181]. - The company had a net revenue of $178.0 million for the six months ended March 31, 2025, with a gross profit of $60.1 million[181].